An ideal way to keep informed of the dealmaking activity of 50 of the top pharmaceutical companies.
Partneringdesk™ Deals Briefings provide a comprehensive summary of the deals and alliances announced by 50 of the top pharmaceutical and biotechnology companies and subsidiaries, each covering the period January 2001 to March 2006.Buying Partneringdesk Deals Briefings
The reports include a brief company profile, a financial data and deals overview, and a detailed listing of the company’s deals and alliances.
Information breakdown for every deal entry includes:
- Date of announcement
- Partners
- Deal type
- Industrial sector
- Therapy sector
- Stage of development (where disclosed)
- Deal exclusivity (where disclosed)
- Total deals value (where disclosed)
- Financials (where disclosed)
Comprehensive summary of the last 5 years of deal-making by the industry’s top 50 pharmaceutical and biotech companies.
Other selected research from the 'Business Development' category:
Partneringreview 2006 - Industry sector (volume 6)
Partnering Agreements with Forest 2010
The Partnering Agreements with Forest 2010 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand Forest Labs and its partnering interests and activities over the past five years. Learn More
This report provides all the information you require to better understand Forest Labs and its partnering interests and activities over the past five years. Learn More
Other selected research from the 'Companies' category:
Les Laboratoires Servier: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Servier in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. Learn More
PharmaVitae 2004: Almirall Global Analysis
This analysis examines the current position and future outlook for Almirall in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-7 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. Learn More